Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.

PURPOSE Aggressive melanoma cells may express endothelial markers that can be used to calculate microvascular density (MVD). High MVD has been associated with adverse outcome in uveal melanoma. If tumor cells label with endothelial cell markers, then MVD may not accurately reflect a tumor's vascularity. This study was designed to study the influence of melanoma cell labeling by endothelial cell markers on MVD. METHODS Tissue sections of 200 ciliary body or choroidal melanomas were stained with CD34 alone, and the MVD was calculated by counting discrete foci of CD34 labeling in hot spots, as described previously. From adjacent sections double labeled by fluorescent immunohistochemical stains for S100 protein and CD34, tumor cells labeling with both markers were identified. The relationship between marker coexpression and MVD was tested. Tissue sections were also double labeled for Melan-A and CD34. RESULTS MVD was found to be associated with death from metastatic melanoma as reported previously. However, colocalization of both Melan-A and S100 protein with CD34 was demonstrated. The labeling of tumor cells by CD34 was associated with an elevated calculation of MVD (P < 0.0001) but not with cell type, mitotic figures, tumor-infiltrating lymphocytes, or PAS-positive patterns. CONCLUSIONS CD34 may label uveal melanoma cells and may contribute to computation of MVD. Although MVD is prognostically significant in uveal melanoma, this feature is not an exclusive measure of tumor vascularity.

[1]  S. Shapiro,et al.  An Analysis of Variance Test for Normality (Complete Samples) , 1965 .

[2]  D. Cox.  Regression Models and Life-Tables , 1972 .

[3]  Douglas A. Wolfe,et al.  Nonparametric Statistical Methods , 1973 .

[4]  K. Messmer,et al.  The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis. , 1985, International journal of microcirculation, clinical and experimental.

[5]  C. Streffer,et al.  The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies. , 1989, Acta anatomica.

[6]  I. McLean,et al.  Lymphocytic infiltration in uveal malignant melanoma , 1990, Cancer.

[7]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[8]  S. T. Traweek,et al.  The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. , 1991, American journal of clinical pathology.

[9]  B. Nickoloff.  The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. , 1991, Archives of dermatology.

[10]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[11]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[12]  R. Folberg,et al.  The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. , 1992, Human pathology.

[13]  W. Dupont,et al.  Breast cancer angio-histogenesis: through a narrow window. , 1992, Journal of the National Cancer Institute.

[14]  R. Folberg,et al.  The prognostic value of tumor blood vessel morphology in primary uveal melanoma. , 1993, Ophthalmology.

[15]  I. Ellis,et al.  Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? , 1995, Human pathology.

[16]  D. Carney,et al.  Prognostic significance of microvessel density in lymph node negative breast carcinoma. , 1995, Human pathology.

[17]  D. Page,et al.  Angiogenesis in human breast carcinoma: what is the question? , 1995, Human pathology.

[18]  T. Kivelä.  Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology. , 1995, British journal of biomedical science.

[19]  Y. Ohnishi,et al.  Histologic findings and prognosis of uveal malignant melanoma in japanese patients. , 1996, American journal of ophthalmology.

[20]  S. Hughes,et al.  Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. , 1996, Experimental cell research.

[21]  A. Harris,et al.  Microvessel count predicts survival in uveal melanoma. , 1996, Cancer research.

[22]  E. Gragoudas,et al.  An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma , 1997, Melanoma research.

[23]  M. Burnier,et al.  Uveal melanoma: Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size , 1997 .

[24]  N. Weidner,et al.  Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.

[25]  S. Seregard,et al.  Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. , 1998, Ophthalmology.

[26]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[27]  Z. Orosz.  Melan‐A/Mart‐1 expression in various melanocytic lesions and in non‐melanocytic soft tissue tumours , 1999, Histopathology.

[28]  A. Tarkkanen,et al.  Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. , 1999, Investigative ophthalmology & visual science.

[29]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[30]  R K Jain,et al.  Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Lucas,et al.  Contrasting effects of HSP72 expression on apoptosis in human umbilical vein endothelial cells and an angiogenic cell line, ECV304 , 2000, British journal of haematology.

[32]  J. Greer,et al.  Immunohistochemical characterization of thyroid gland angiomatoid tumors. , 2000, Experimental and molecular pathology.

[33]  R. Jain,et al.  Vasculogenic mimicry: how convincing, how novel, and how significant? , 2000, The American journal of pathology.

[34]  R Folberg,et al.  Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.

[35]  S. Heegaard,et al.  Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45 , 2000, Melanoma research.

[36]  D. Majumdar,et al.  Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. , 2000, Cancer research.

[37]  Paul S. Meltzer,et al.  Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Ruiter,et al.  Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. , 2001, Investigative Ophthalmology and Visual Science.

[39]  J. Folkman.  Can mosaic tumor vessels facilitate molecular diagnosis of cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Sapino,et al.  Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast , 2001, The Journal of pathology.

[41]  R. Bentley,et al.  CD34 expression in desmoplastic melanoma , 2001, Journal of cutaneous pathology.

[42]  D. Brat,et al.  Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. , 2001, Journal of the American Academy of Dermatology.

[43]  K. Smith,et al.  CD34‐positive cellular blue nevi Note , 2001, Journal of cutaneous pathology.

[44]  O. A. Jensen,et al.  Scanning electron microscopy of frozen-cracked, dry-cracked and enzyme-digested tissue of human malignant choroidal melanomas , 2004, Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie.

[45]  A. Paetau,et al.  CD34 immunoreactivity in nervous system tumors , 2004, Acta Neuropathologica.